Home priced
 

Keywords :   


Tag: priced

BP: Is A Dividend Cut Priced In At This Level?

2016-01-21 14:21:21| Oil & Gas - Topix.net

Persistent supply glut and weak price forecasts imply higher bankruptcy risk for smaller, independent oil companies, but big oil should make it through this downturn. Oil companies are really not in a good spot at the moment.

Tags: this level cut priced

 

Competitively Priced New and Recertified Blood Gas Analyzers Available at Block Scientific

2016-01-15 11:31:11| Industrial Newsroom - All News for Today

A leading lab equipment supplier based in New York, Block Scientific offers blood gas analyzers from leading brands at competitive prices. The company is a reliable source of high quality new and recertified instruments from top manufacturers such as Bayer, Medica, Siemens and Radiometer. All the instruments that...

Tags: scientific blood block gas

 
 

'If it's priced well, it will sell,' Realtors say about a year of housing-market recovery

2016-01-05 15:25:00| Real Estate - Topix.net

After several years of ups and downs, 2015 was a year Realtors say the housing market started to recover for the Harrisburg region. It's been a slow recovery, but the 2015 numbers are showing more than a glimmer of hope: The housing market in the Harrisburg region very well could be rebounding.

Tags: of year sell recovery

 

NuStar Logistics' Subordinated Notes: Fairly Priced, Or Misvalued By The Market?

2015-12-21 20:51:43| Steel - Topix.net

Is the recent sell-of in NuStar Logistics L.P.'s 7.625% Fixed-to-Floating Rate Subordinated Notes a buying opportunity? "NSS" are fixed-to-floating subordinated notes of NuStar Logistics, L.P., with a B+ rating from S&P, issued on 1/14/2013. The parent guarantor of the notes is NuStar Energy, L.P. .

Tags: the market notes fairly

 

Alexion: 2 Global Drug Rollouts, But Upside Already Priced In

2015-12-06 11:18:40| Biotech - Topix.net

Alexion is highly overvalued, even assuming best case peak sales projections of $1B for Strensiq, $1B for Kanuma, and $5B for Soliris. Payer risk for high-priced drugs isn't going away and orphan drug companies can't expect to keep getting a free pass.

Tags: in global drug priced

 

Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] next »